Clinical Trials Logo
  1. Home
  2. Keratosis, Actinic
  3. NCT05481073
  4. Details
NCT05481073 Clinical Trial

UV Sensor in Patients With Actinic Keratosis

Keratosis, Actinic Clinical Trial

Official title:
Pilot Feasibility Study of Using UV Sensor in Patients With Actinic Keratosis

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05481073
Other study ID # Usability UV sensor study
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 13, 2022
Est. completion date September 1, 2022

Study information
Verified date November 2022
Source Almirall, S.A.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To validate the use of Ultraviolet (UV) radiation sensor in patients with actinic keratosis, to identify barriers to its use in prospective longitudinal studies.

Description:

To prevent both acute and chronic damage from exposure to UV A and UV B radiation. Personal UV exposure can be assessed by portable sensors. Having an accurate awareness of one's own behavior (assessed by the accuracy of the UV sensor), can motivate and engage with skin protection.

Recruitment information / eligibility
Status Completed
Enrollment 10
Est. completion date September 1, 2022
Est. primary completion date August 2, 2022
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: >=65 years presenting actinic keratosis on scalp and/or face Exclusion Criteria: Patients who, due to health problems or lifestyle habits, do not expose themselves regularly to UV radiation (outdoor) for at least one hour a day.

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• UV sensor
Use of UV sensor to be informed about the sun exposure daily through a mobile application

Locations
Country Name City State
Spain Dermatology Unit (Hospital Clinic) Barcelona

Sponsors (1)
Lead Sponsor Collaborator
Almirall, S.A.

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary QOL UV sensor Questionnaire will be carried out to qualitatively evaluate different aspects of the usability of the UV device, Minimum Value 0; Maximun Value 20, where higher value is the better. Up to week 4
See also
  Status Clinical Trial Phase
Completed NCT03076892 - Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS N/A
Terminated NCT03076918 - Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy N/A
Completed NCT05356572 - A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty Skin N/A
Recruiting NCT05387525 - A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp Phase 4
Completed NCT02594644 - The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy N/A
Active, not recruiting NCT02281682 - IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis Phase 4
Completed NCT01458587 - Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK) Phase 2
Completed NCT05260073 - Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
Active, not recruiting NCT06014697 - OCT and Invasion in Cutaneous Skin Lesions
Completed NCT05279131 - A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis Phase 3
Completed NCT03697590 - Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage Phase 4
Withdrawn NCT02813902 - A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors Phase 1
Recruiting NCT05636800 - Microwave Treatment for Actinic Keratosis N/A
Completed NCT02628236 - Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2) Phase 2
Recruiting NCT06135415 - A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis Phase 3
Completed NCT02644187 - Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol N/A
Completed NCT02281136 - MUSE Study of Levulan Kerastick Phase 2
Completed NCT05060237 - Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp Phase 1
Terminated NCT04269395 - A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study Phase 3